Computational infrastructure for discovery
A new drug takes 12 years to reach a patient. A new material can take longer. Most of that time is spent waiting — for data, for compute, for compliance checks, for the next tool in the chain. NovoQuantNexus builds the infrastructure that eliminates the waiting.
Drug Discovery
From target identification to patient stratification. 122 million pre-computed compounds, GPU docking, molecular dynamics, and clinical outcome prediction — nine autonomous stages, one platform.
Explore Drug Discovery →Materials Science
OLED emission screening, electrolyte voltage stability, reaction feasibility, activation barriers, inorganic discovery. Every element in the periodic table. Same endpoint.
Explore Materials Science →Latest
We build infrastructure so researchers can focus on the science.
The bottleneck in drug discovery is not the science — it is the infrastructure between the science. Every handoff between tools, every compliance check deferred to the end, every week waiting for compute access is time that compounds into years.
NovoQuantNexus pre-computes the knowable, automates the routine, and keeps the researcher at the center of every decision that matters. The platform checks in when judgment is needed. The rest runs.